Diabetes Care:2型糖尿病患者的抑郁研究

2016-10-15 MedSci MedSci原创

众所周知,2型糖尿病出现抑郁,与长期并发症、残疾和早期死亡率有关,但是关于2型糖尿病(T2D)和重度抑郁症(MDD)患者的抑郁持续时间、缓解时间等的研究尚缺乏。 研究纳入了50例T2D+MDD成年患者,进行行为干预,使用结构化临床采访,对患者进行评估,在基线、干预后、随访3个月时,使用DSM-IV-TR评估患者的抑郁情况。从出生到最后一次随访,记录了所有抑郁发作和缓解情况。 数据显示,

众所周知,2型糖尿病出现抑郁,与长期并发症、残疾和早期死亡率有关,但是关于2型糖尿病(T2D)和重度抑郁症(MDD)患者的抑郁持续时间、缓解时间等的研究尚缺乏。

研究纳入了50例T2D+MDD成年患者,进行行为干预,使用结构化临床采访,对患者进行评估,在基线、干预后、随访3个月时,使用DSM-IV-TR评估患者的抑郁情况。从出生到最后一次随访,记录了所有抑郁发作和缓解情况。

数据显示,MDD发作的平均次数为1.8次,平均持续时间为23.4个月(SD 31.9;范围0.5–231.3)。在生命历程中,暴露于MDD的平均时间为43.1个月(SD 46.5;范围0.5–231.3)。Kaplan-Meier生存曲线分析显示,下一次发作时的平均发作持续时间下降(第一次发作,14个月;第二次发作,9个月;P < 0.002)。对于多次抑郁发作的患者,下一次发作的恢复时间更短(P = 0.002)。基于T2D诊断年表,没有发现抑郁发作持续时间或缓解持续时间的差异。

结果表明,T2D患者相当长时间暴露于抑郁症中,会导致较差的医疗和精神结局。不管是抑郁发作持续时间还是恢复持续时间都在一次次的缩短。这项研究的结果强调了对T2D患者的抑郁进行有效地诊断和治疗,以减少未来抑郁症发作的风险。

原始出处:

Mary de Groot,et al.Lifetime Duration of Depressive Disorders in Patients With T2D.Diabetes Care 2016 Oct

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759787, encodeId=4db01e597876a, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue May 02 06:15:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637508, encodeId=e61c163e50802, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 08 19:15:00 CST 2017, time=2017-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901476, encodeId=c40c19014e664, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Feb 10 22:15:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383261, encodeId=cd571383261d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474080, encodeId=fecd14e408072, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1759787, encodeId=4db01e597876a, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue May 02 06:15:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637508, encodeId=e61c163e50802, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 08 19:15:00 CST 2017, time=2017-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901476, encodeId=c40c19014e664, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Feb 10 22:15:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383261, encodeId=cd571383261d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474080, encodeId=fecd14e408072, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1759787, encodeId=4db01e597876a, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue May 02 06:15:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637508, encodeId=e61c163e50802, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 08 19:15:00 CST 2017, time=2017-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901476, encodeId=c40c19014e664, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Feb 10 22:15:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383261, encodeId=cd571383261d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474080, encodeId=fecd14e408072, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1759787, encodeId=4db01e597876a, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue May 02 06:15:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637508, encodeId=e61c163e50802, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 08 19:15:00 CST 2017, time=2017-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901476, encodeId=c40c19014e664, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Feb 10 22:15:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383261, encodeId=cd571383261d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474080, encodeId=fecd14e408072, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1759787, encodeId=4db01e597876a, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue May 02 06:15:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637508, encodeId=e61c163e50802, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 08 19:15:00 CST 2017, time=2017-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901476, encodeId=c40c19014e664, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Feb 10 22:15:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383261, encodeId=cd571383261d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474080, encodeId=fecd14e408072, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Oct 17 07:15:00 CST 2016, time=2016-10-17, status=1, ipAttribution=)]

相关资讯

Diabet Med:2型糖尿病患者血糖控制情况对各种感染的发生有何影响?

本研究旨在探究2型糖尿病患者血糖控制对感染发生率的影响。研究人员对比了2014年2型糖尿病患者与非糖尿病患者的感染率,数据来源于英国的一个大型初级保健队列(皇家全科医师学会研究和监测中心数据库)。采用多层次logistic回归分析探讨2型糖尿病对感染的影响,以及血糖控制对上呼吸道感染、支气管炎、流感样疾病,肺炎、肠道传染病、单纯疱疹、皮肤及软组织感染、尿路感染、生殖器和会阴感染的影响。根据患者最近

Diabetes Care:母亲孕期患妊娠期糖尿病,会增加后代2型糖尿病风险

本研究旨在探讨宫内妊娠期糖尿病(GDM)暴露和第一民族(FN)状态,对后代生命前30年的2型糖尿病风险的影响。 第一民族(First Nations,FN),是一个加拿大的种族名称,与印地安人(Indian)同义,指的是在现今加拿大境内的北美洲原住民及其子孙,但是不包括因努伊特人和梅提斯人。 在这项历史前瞻性队列研究中,我们通过临床数据库,调查了GDM和FN状态与后代2型糖尿病风险之间

2015NICE指南——成人2型糖尿病的管理(NG.28)发布

2015年12月,英国国家卫生与临床优化研究所 (NICE)发布了成人2型糖尿病的管理指南。全文获取:下载地址:指南下载(需要扣积分2分, 梅斯医学APP免积分下载) 

糖尿病新药进展!武田2型糖尿病复方药Inisync(阿格列汀/二甲双胍)获日本批准

日本制药巨头武田(Takeda)近日宣布,日本卫生劳动福利部(MHLW)已批准糖尿病复方新药Inisync复方片,用于2型糖尿病的治疗。Inisync复方片由固定剂量的Nesina(阿格列汀,alogliptin,25mg)和二甲双胍(500mg)组成,每日口服一次。此次批准,使Inisync成为日本市场唯一一种每日口服一次的DPP-4和二甲双胍复方药。 Inisync的获批,是基于与Nes

JAMA:LDL-C降脂基因突变可增加2型糖尿病的发病风险

NPC1L1和HMGCR分别是编码依泽替米贝和他汀类药物的分子靶点,在或接近这两个基因的低密度脂蛋白胆固醇(LDL-C)降脂等位基因曾用于探究这些降脂药物的疗效。靠近HMGCR的等位基因与有较高的2型糖尿病的发病风险有关,与他汀类药物治疗与新发糖尿病的发病率增加有关相似。但是,靠近NPC1L1的等位基因是否与2型糖尿病的发病风险增加有关则尚未可知。本研究旨在探究在或靠近NPC1L1的LDL-C降脂

JACC:如何抑制2型糖尿病患者的心力衰竭?

患冠状动脉疾病的心力衰竭患者并发2型糖尿病,只要使用有效的治疗方法是可以预防的。发表在《美国心脏病学会杂志》上的一个大型研究称,来自卡罗林斯卡医学院的研究人员表明,在还没有诊断出患有心力衰竭时的2型糖尿病患者进行冠状动脉手术会有更好的长期生存的机会。 相比没有患糖尿病的人,伴有2型糖尿病的心力衰竭患者发病会更严重。一般情况下,心力衰竭是由于冠心病引起的(CAD)。为了改善心肌供血,冠